Early salpingectomy (TUbectomy) with delayed oophorectomy to improve quality of life as alternative for risk-reducing salpingo-oophorectomy in BRCA1/2 mutation carriers (TUBA study): a prospective non-randomised multicentre studyMarline G. Harmsen, Joanne A. de Hullu, M.A.D.W. de Jong et al.|BMC Cancer|2015Cited by 106
Association of Salpingectomy With Delayed Oophorectomy Versus Salpingo-oophorectomy With Quality of Life in <i>BRCA1/2</i> Pathogenic Variant CarriersMiranda P. Steenbeek, Joanne A. de Hullu, Marline G. Harmsen et al.|JAMA Oncology|2021Cited by 78
Peritoneal carcinomatosis after risk‐reducing surgery in <i>BRCA1/2</i> mutation carriersMarline G. Harmsen, Joanne A. de Hullu, Murray Joseph Casey et al.|Cancer|2018Cited by 40
The Paget Trial: A Multicenter, Observational Cohort Intervention Study for the Clinical Efficacy, Safety, and Immunological Response of Topical 5% Imiquimod Cream for Vulvar Paget DiseaseM. van der Linden, Joanne A. de Hullu, K.A.P. Meeuwis et al.|JMIR Research Protocols|2017Cited by 29
Characteristics of Lynch syndrome associated ovarian cancerJorien M. Woolderink, Marian J.E. Mourits, Geertruida H. de Bock et al.|Gynecologic Oncology|2018Cited by 29